These observations are in line with the results published by Steinmetz et al. and Toledano et al., where the supplementation with FCM only, in anaemic cancer patients with absolute iron deficiency under chemotherapy, led to a substantial and sustained increase in Hb levels, suggesting a role for IV iron as first-line treatment for CIA23,24. The gene discussed is GSTM1; the disease is nutritional disorder.